How peptides support gut health
Studied in the gut lining
This list of the best peptides for gut health covers BPC-157, KPV, TB-500 and KLOW, the Peppi blend that carries the other three. Each is here because its gut research, or its parent molecule's, was run in rats, mice or human cell lines. At Peppi, BPC-157 and KLOW come as their own ready-to-use, pre-filled pens, and KPV and TB-500 come inside Peppi's blends. A clinician licensed in your state reviews your intake before anything ships. None has a published trial in people showing it improves gut health.
Most of that research looks at one place: the gut lining.
The journal Gut, in a 2019 review, describes the intestinal barrier as three parts: surface mucus, a layer of epithelial cells and immune defenses. Studies of peptides for gut health injure or inflame that lining in an animal, give a peptide, then score what the tissue looks like and which inflammatory signals it makes. In a rat or a mouse, a better score is a lead for more study. It is not a result in a person.
Quality is the part you can check yourself. Every Peppi batch is tested by independent labs for potency, sterility, pH and endotoxicity before it ships, and you can look up Peppi's batch test results by the lot number printed on your pen label.
The short answer
BPC-157's gut research is nearly all in rats. KPV's comes from human cell lines and mice, and TB-500's gut story belongs to its parent protein, with mixed results. KLOW carries all three plus GHK-Cu in one ready-to-use, pre-filled pen, though the blend itself has not been tested in people. A licensed clinician reviews your intake before anything ships.
- Number 1.
BPC-157 for gut health
From human gastric juice
$149
$299first monthStudied forGut support, anti‑inflammatory, tissue & tendon repair
In the pen10 mg BPC‑157
Gut evidenceRat models
Price$299 one‑time, or 50% off your first month by subscription
BPC-157 leads this list because its story starts in the stomach. Peppi's product page describes it as a lab-made peptide of 15 amino acids, based on a fragment of a protein first isolated from human gastric juice.
The studies below on BPC 157 for gut health trace back to rats, and to one research group at the University of Zagreb.
In the 2017 BPC 157 colitis study in World Journal of Gastroenterology, that group tied off the blood supply to a segment of colon in rats. Segments bathed in BPC-157 kept their mucosal folds and showed smaller pale areas than segments bathed in saline. A 2013 study from the same group, in the Journal of Physiology and Pharmacology, induced colitis in rats with a chemical called cysteamine. Untreated rats did not recover during the study, and rats given BPC-157 did.
BPC 157 oral use has rat data too: in that 2013 paper, some rats got the peptide by injection into the abdomen and others in their drinking water. Peppi does not offer oral capsules.
Searches for BPC 157 leaky gut research turn up review articles. A 2020 review in Current Pharmaceutical Design, co-written by a Zagreb author, describes the peptide's potential against the gut permeability that NSAID pain relievers can cause. It is a review, not a trial in people.
At Peppi, BPC-157 for gut health goals means the single-peptide pen. It holds 10 mg as a one-month supply, and Peppi lists it as studied for tissue and tendon repair, gut support and anti-inflammatory. The same page notes that BPC-157 "has limited research in people" and "is not approved to treat any condition." A licensed clinician reviews your intake and determines whether it's appropriate for you.
- Tagged Gut Support on its Peppi page
- Ready‑to‑use, pre‑filled pen
- Your clinician sets the dose
- Number 2.
KPV peptide for gut inflammation
Three amino acids, one tail
Studied forGut inflammation, in cells & mice
In Peppi's pens10 mg in KLOW
Gut evidenceHuman cell lines & mouse models
KPV is the peptide on this list whose research is about gut inflammation first. The KPV peptide is three amino acids long (lysine, proline and valine), and Peppi's KLOW page places it at the tail end of the hormone alpha-MSH.
Most KPV benefits you'll read about come from one 2008 paper in Gastroenterology. Its authors stimulated human intestinal and immune cell lines with inflammatory messengers. With KPV present, NF-kappaB and MAP kinase signaling were inhibited and the cells released fewer pro-inflammatory cytokines. The same team added KPV to the drinking water of mice with chemically induced colitis, and the treated mice showed lower expression of pro-inflammatory signaling molecules.
The paper also explains how KPV gets in. PepT1, a transporter found on cells of the gut lining and on immune cells, carried it inside.
That is the whole chain so far: cells, then mice.
Peppi's KLOW page says KPV has "no published human trials yet." Peppi does not sell KPV alone. It comes at 10 mg inside the KLOW pen.
- Tested in human cell lines & in mice
- Three amino acids from alpha‑MSH
- At Peppi, only inside KLOW
TryKLOW Stack$224 - Number 3.
TB-500 & the gut lining
A fragment of thymosin beta-4
Studied forThe gut lining, as thymosin beta‑4, in mice
In Peppi's pens10 mg in Wolverine, KLOW & GLOW
Gut evidenceParent protein only, mixed
TB-500's link to the gut lining runs through its parent protein, thymosin beta-4. A 2012 doping-control paper in the Journal of Chromatography A describes TB-500 as a synthetic version of a seven-amino-acid segment of that protein.
Search for TB500 and gut health and the published record is thin. PubMed, searched in November 2026 for TB-500 with gut, intestine or colitis, returned one paper, a poultry feed study where "TB-500" labels a feed supplement mix.
The parent protein has more, and it points both ways. In a 2017 mouse study in World Journal of Gastroenterology, researchers used a gene-delivery virus to make colon tissue produce thymosin beta-4. In two chemically induced colitis models, those mice had milder colon injury and fewer inflammatory cells. A 2025 study in the same journal found high thymosin beta-4 in colon mucus from people with irritable bowel syndrome. When its authors gave the protein to mice, tight junction proteins in the gut lining went down, a change the paper ties to a weaker barrier.
Neither study tested the TB-500 fragment.
Peppi doesn't sell TB-500 alone. Peppi's Wolverine pen pairs 10 mg of it with 10 mg of BPC-157, and the KLOW and GLOW pens carry the same two. Peppi's Wolverine page notes that TB-500 on its own has no published human trials yet, so a clinician weighs your goals before prescribing.
TryWolverine Stack$189 - Number 4.
KLOW for gut & skin
Four peptides in one pen
$224
$449first monthStudied forAnti‑inflammatory, advanced tissue repair, advanced skin glow
In the penBPC‑157 10 mg, TB‑500 10 mg, GHK‑Cu 50 mg, KPV 10 mg
Gut evidenceFrom its parts, not the blend
Price$449 one‑time, or 50% off your first month by subscription
KLOW closes the list because it holds every peptide above and adds one for skin. Peppi's product page puts it in one line: "KLOW builds on GLOW (BPC-157, TB-500, GHK-Cu) and adds KPV, an anti-inflammatory tripeptide." That makes Peppi's KLOW pen the only Peppi pen with KPV.
BPC-157 and KPV, 10 mg each, are the two with the gut research above. TB-500 adds 10 mg, and GHK-Cu, 50 mg, is a copper peptide. Peppi's KLOW page credits GHK-Cu with collagen findings in skin cell studies and small studies of creams, and adds that "human data on injectable GHK-Cu are limited."
Read KLOW peptide benefits as the sum of separately studied parts. The rat, mouse and cell findings above each belong to one peptide, and Peppi states that no trial has tested the KLOW blend itself in people.
What the blend changes is practical. Four peptides arrive in one pen with a twist-to-dose selector and nothing to mix or measure, at the dose your clinician sets from your intake.
- The only Peppi pen with KPV
- Gut & skin peptides in one pen
- No mixing or measuring
Peptides for IBS
What the research covers
No peptide on this list has been tested in people with irritable bowel syndrome, so none of them belongs on a list of peptides for IBS. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes IBS as a group of symptoms that occur together, including repeated abdominal pain and changes in bowel movements.
PubMed searches in November 2026 pairing BPC-157 or KPV with irritable bowel returned no papers. Thymosin beta-4 returned one, the 2025 study above, which looked at the body's own protein as a possible contributor to IBS.
NIDDK lists what doctors do use: changes in what you eat, other lifestyle changes, medicines, probiotics and mental health therapies.
If you have IBS symptoms, a doctor who can examine you is the place to start.
Oral vs injectable peptides for the gut
How each was given
No published study in people settles oral vs injectable BPC 157. A PubMed search in November 2026 for human studies comparing the two routes returned nothing. KPV and TB-500 on their own have no published human trials yet, per Peppi's product pages.
What exists is a record of how each peptide was given to animals.
| Study | How it was given | Studied in |
|---|---|---|
| BPC-157, 2013 study | Injection into the abdomen or in drinking water | Rats |
| BPC-157, 2017 study | Applied directly to the colon | Rats |
| KPV, 2008 study | In drinking water | Mice, plus human cell lines |
| Thymosin beta-4, 2017 study | Gene delivery into the colon | Mice |
Because a route used in a rat is not evidence for that route in a person, the table can't pick a winner.
The format question has a simpler answer at Peppi. Each pen is a ready-to-use, pre-filled pen that injects under the skin, with a fresh needle for every dose and no reconstituting or mixing. Peppi's how to use page covers the pen itself, and your clinician's instructions come first.
Peppi's Wolverine, KLOW, BPC-157 and GLOW pens are compounded prescription peptides, filled by a licensed U.S. pharmacy after clinician review, and are not FDA-approved.
Not sure which recovery pen fits your goals?
Take the QuizGetting started takes under 2 minutes online. A clinician licensed in your state reviews your intake, in most cases within 24 hours, and a licensed U.S. pharmacy fills the prescription. If your prescription isn't approved, you get a 100% refund. Peppi notes that peptide therapy is cumulative and recommends 4 to 6 months for results to build.

Featured pen
KLOW
BPC-157, TB-500, GHK-Cu and KPV in one ready-to-use, pre-filled pen. A clinician licensed in your state reviews your intake before anything ships.
Questions about peptides for gut health
Frequently asked questions
Is BPC-157 Good for Leaky Gut?
No study in people has tested BPC-157 for leaky gut. A PubMed search in November 2026 returned two papers on the pairing, both review articles. A 2019 review in the journal Gut adds that it is still unproven that restoring barrier function improves symptoms. Peppi lists its BPC-157 pen as studied for gut support, and a licensed clinician determines whether it's appropriate for you.
Should Gut Peptides Be Oral or Injected?
No published study in people compares the two routes for BPC-157, KPV or TB-500. In the animal studies cited here, rats and mice received peptides in drinking water, by injection or directly on the colon. Peppi's pens are injected under the skin, and Peppi does not offer oral capsules. A licensed clinician sets your dose from your intake.
How Long Does BPC-157 Take to Work for Gut Health?
No human trial has measured that, and Peppi's BPC-157 page says any exact timeline is a guess. The rat colon studies cited here checked tissue within days to two weeks, and animal timelines may not match people. Peppi notes that peptide therapy is cumulative and recommends 4 to 6 months for results to build. Response varies by person.
These peptides are not FDA-approved and are dispensed only with a prescription.
Peptide guides from Peppi
Keep reading



















